FDA approves Voquezna for erosive esophagitis, GERD
The U.S. Food and Drug Administration has approved Phathom Pharmaceuticals' Voquezna (vonoprazan), a novel potassium-competitive acid blocker, as a new treatment for adults for with all grades of erosive esophagitis or erosive ...
Nov 8, 2023
0
0